I’ve written much on this blog about the terrible consequences of the U.S. Supreme Court’s ruling in PLIVA v. Mensing. In that case, the Court found that victims of injuries…
Read More
Hospira, the manufacturers of a generic version of the acid reflux drug Reglan, has issued a recall of the pills after it was discovered that the drug contained strands of…
Because I practice pharmaceutical injury law nationwide, I’ve been very interested in the debate over “innovator liability” in Alabama. That’s the name for the legal theory the Alabama Supreme Court…
In the past few years, the U.S. Supreme Court has made life even tougher for victims of injuries caused by generic prescription drugs. In PLIVA v. Mensing, the Court barred…
According to recent reports, the acid reflux drug Reglan is now facing new restrictions in Europe because of the drug’s link to neurological disorders like tardive dyskinesia. These new restrictions…
Last month, I wrote here as a dangerous drug lawyer about an Eighth U.S. Circuit Court of Appeals decision involving claims against generic and name-brand Reglan makers. In Bell v….
Last week, I wrote as a pharmaceutical liability lawyer about a generic Reglan injury lawsuit at the U.S. Supreme Court, which closed another legal avenue of recovery against drug manufacturers….
As I’ve written here many times, the appeals courts have not yet settled whether and how injured people may pursue payment for injuries caused by defective generic prescription drugs. After…
As a pharmaceutical liability lawyer, I’ve written several posts here recently about generic Reglan lawsuits. Generic versions of Reglan, a drug for gastroesophageal reflux disease, have been the subjects of…
Pfizer, the makers of the acid reflux drug Reglan, filed a rehearing request on February 19 that is asking the Alabama Supreme Court to reconsider one of its recent rulings…